(170 days)
Not Found
No
The document explicitly states "Not Applicable as there are no new or innovative aspects that have been introduced" for sections typically associated with AI/ML development and validation (training set, test set, performance studies). Additionally, there are no mentions of AI, DNN, or ML in the text.
Yes.
The device is clearly indicated for the "symptomatic relief and management of chronic intractable pain and/or as an adjunctive treatment in the management of post-surgical and post-traumatic acute pain," which are therapeutic applications.
No
The device is described as providing symptomatic relief and management of pain by transmitting electrical pulses, not by identifying or diagnosing a condition.
No
The device description explicitly states that the TENS devices "transmit electrical pulses through the skin," indicating a hardware component responsible for generating and delivering these pulses. This is not a software-only function.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. These tests are performed outside of the body (in vitro).
- Device Description: The description clearly states that the TENS devices "transmit electrical pulses through the skin to the underlying peripheral nerves". This is a treatment applied to the body, not a test performed on a sample from the body.
- Intended Use: The intended use is for "symptomatic relief and management of chronic intractable pain and/or as an adjunctive treatment in the management of post-surgical and post-traumatic acute pain." This describes a therapeutic application, not a diagnostic test.
The information provided describes a therapeutic device used for pain management, not a diagnostic device used for testing samples.
N/A
Intended Use / Indications for Use
TENS is used for the symptomatic relief and management of chronic intractable pain and/or as an adjunctive treatment in the management of post-surgical and post-traumatic acute pain.
The 804SIII, 804W, Libra TENS, 410 and S-TENSII are used for the symptomatic relief and management of chronic intractable pain and/or as an adjunctive treatment in the management of post-surgical and post-traumatic acute pain.
Product codes (comma separated list FDA assigned to the subject device)
GZJ
Device Description
The TENS devices are used to transmit electrical pulses through the skin to the underlying peripheral nerves to aid in the blocking of pain signals travelling to the brain.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 882.5890 Transcutaneous electrical nerve stimulator for pain relief.
(a)
Identification. A transcutaneous electrical nerve stimulator for pain relief is a device used to apply an electrical current to electrodes on a patient's skin to treat pain.(b)
Classification. Class II (performance standards).
0
Coa1846
This 510(k) summary of safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
The assigned 510(k) number is:
10.1 Submitter's Identification:
Body Clock Health Care Ltd 108 George Lane South Woodford London E18 1AD United Kingdom +44 (0)20 8532 9551 Tel: Fax: +44 (0)20 8532 9551
3532 9551
3532 9551
Contact: Jonathan Bash May 30" 2002 Date Prepared:
10.2 Name of Device:
Proprietary Name:
- ﻨﺴ 804SIII 804W 11. Libra TENS III. IV. 410
- S-TENS II V.
Common or Usual Name:
TENS unit (Transcutaneous Electrical Nerve Stimulator)
Classification Name:
Stimulator, Nerve, Transcutaneous, For Pain Relief.
10.3 Predicate Device Information:
The 804SIII, 804W, Libra TENS, 410 and S-TENSII are equivalent to the FUJI TENS 804SIII (K893874). The 804W and Libra TENS also have pulse width adjustment. The 410 is also equivalent to the FUJI TENS Myostim 410 (K853719)
10.4 Device Description:
The TENS devices are used to transmit electrical pulses through the skin to the underlying peripheral nerves to aid in the blocking of pain signals travelling to the brain.
NOV 2 2 2002
1
10.5 Intended Use:
TENS is used for the symptomatic relief and management of chronic intractable pain and/or as an adjunctive treatment in the management of post-surgical and post-traumatic acute pain.
10.6 Technological Comparison to Predicate Devices:
The 804SIII, 804W, Libra TENS, 410 and S-TENS II have basic technological characteristics that are substantially equivalent to the predicate device.
The 804SIII is identical to the FUJI TENS 804SIII (K893874). The 804W is slightly different to the 804SIII. There is only one dial for pulse rate adjustment with both the left and right channels controlled by the one dial as opposed to having two independent user controls. It is additionally capable of Pulse Width Adjustment. The Libra TENS has similar internal workings to the 804W. The only functional difference is a timer switch, which allows the user to leave the unit on for a timed 30 minutes. The 410 is a single channel unit with one adjustable Pulse Rate dial and one adjustable Output dial. The S-TENS II is a single channel unit with one adjustable Pulse Rate dial, one Output dial and a switch option for Burst, Continuous or Modulation.
All units use "shrouded patient cable connector's" to comply with the FDA's Final Rule "Medical Devices: Establishment of Performance Standards for Electrode Lead Wires and Patient Cables."
10.7 Non-clinical Testing:
All required sections of the AAMI/ANSI NS-4 Standard were met. All units pass the required IEC 60601-1:1990 + a1:1993 + A2: 1995 standards. All units pass the IEC 601-1:1988 + a1:1991 + A2:1995 standards.
10.8 Clinical Testing:
Not Applicable as there are no new or innovative aspects that have been introduced.
10.9 Conclusions:
The 804SIII. 804W. Libra TENS. 410 and S-TENS II have the same intended use and similar technical characteristics as the FUJI TENS 804SIII (K893874).
The information supplied in this 510(k) illustrate that the devices do not pose any new questions of safety and effectiveness. The 804SIII, 804W, Libra TENS, 410 and S-TENSII are substantially equivalent to the predicate device(s).
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle with three stripes representing the department's mission to promote health, well-being, and human services.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
NOV 2 2 2002
Ms. Rachelle Preston Director of Special Projects Body Clock Health Care Ltd. 108 George Lane South Woodford London E18 1AD United Kingdom
Re: K021846
Trade/Device Name: 804SIII 804W Libra TENS 410 S-TENSIII Regulation Number: 21 CFR 882.5890 Regulation Name: Transcutaneous electrical nerve stimulator for pain relief Regulatory Class: II Product Code: GZJ Dated: August 27, 2002 Received: September 3, 2002
Dear Ms. Preston:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Ms. Rachelle Preston
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours.
Neil R.P. Ogden
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Statement of Indications For Use 8
510 (k) Number (if known): ___________________________________________________________________________________________________________________________________________________ 804SIII Device Name/s: 804W Libra TENS 410 S-TENSII
Indications For Use:
The 804SIII, 804W, Libra TENS, 410 and S-TENSII are used for the symptomatic relief and management of chronic intractable pain and/or as an adjunctive treatment in the management of post-surgical and post-traumatic acute pain.
Nro for cmw
(Division Sign-Off) Division of Creneral, Restorative and Neurological Devices
510(k) Number KC21846